AstraZeneca PLC (AZN.L) Revenue Growth

Price: $11316
Market Cap: $175.47B
Avg Volume: 2.74M
Country: GB
Industry: Drug Manufacturers - General
Sector: Healthcare
Beta: 0.157
52W Range: $9670-13388
Website: AstraZeneca PLC

What is AstraZeneca PLC's Revenue Growth?

  • AstraZeneca PLC's annual revenue growth as of FY 2024 is 18.03%.
  • AstraZeneca PLC's quarterly revenue growth as of Q4 2024 is 9.78%.

What is Revenue Growth?

Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.

Related Metrics

Other important metrics to assess AstraZeneca PLC's financial performance include:

  • Revenue - the total revenue generated by a company:
    • Annual: $54.07B
    • Quarterly: $14.89B
  • Cost of Revenue - the total cost of producing the goods or services sold by a company:
    • Annual: $10.21B
    • Quarterly: $2.73B
  • Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
    • Annual Growth: 26.95%
    • Quarterly Growth: -11.55%
  • Gross Profit - the difference between revenue and the cost of revenue:
    • Annual: $43.87B
    • Quarterly: $12.17B
  • Gross Profit Growth - the rate at which a company's gross profit is growing:
    • Annual Growth: 16.14%
    • Quarterly Growth: 16.04%

These metrics provide insights into AstraZeneca PLC's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual Revenue Growth

18.03%

Quarterly Revenue Growth

9.78%

Historical Annual Revenue Growth
40.58%40.58%31.08%31.08%21.58%21.58%12.09%12.09%2.59%2.59%-6.90%-6.90%Revenue Growth (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Revenue Growth
9.78%9.78%7.23%7.23%4.69%4.69%2.15%2.15%-0.39%-0.39%-2.93%-2.93%Revenue Growth (Quarterly)20232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Historical Annual Revenue
$60.00B$60.00B$50.00B$50.00B$40.00B$40.00B$30.00B$30.00B$20.00B$20.00B$10.00B$10.00B$0.00$0.00Revenue (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Revenue
$16.00B$16.00B$12.00B$12.00B$8.00B$8.00B$4.00B$4.00B$0.00$0.00Revenue (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Annual Cost of Revenue
$15.00B$15.00B$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00Cost of Revenue (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Cost of Revenue
$5.00B$5.00B$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00Cost of Revenue (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Annual Gross Profit
$50.00B$50.00B$40.00B$40.00B$30.00B$30.00B$20.00B$20.00B$10.00B$10.00B$0.00$0.00Gross Profit (Annual)20162016201720172018201820192019202020202021202120222022202320232024202420252025
Historical Quarterly Gross Profit
$15.00B$15.00B$12.00B$12.00B$9.00B$9.00B$6.00B$6.00B$3.00B$3.00B$0.00$0.00Gross Profit (Quarterly)20162016201720172018201820192019202020202021202120222022202320232024202420252025

AstraZeneca PLC Historical Revenue Growth Metrics

The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.

Year Revenue Revenue Growth Cost of Revenue Cost of Revenue Growth Gross Profit Gross Profit Growth
2024 $54.07B 18.03% $10.21B 26.95% $43.87B 16.14%
2023 $45.81B 3.29% $8.04B -35.11% $37.77B 18.18%
2022 $44.35B 18.53% $12.39B -0.37% $31.96B 27.94%
2021 $37.42B 40.58% $12.44B 134.70% $24.98B 17.18%
2020 $26.62B 9.16% $5.30B 7.68% $21.32B 9.53%
2019 $24.38B 10.38% $4.92B -0.30% $19.46B 13.46%
2018 $22.09B -1.67% $4.94B 14.31% $17.15B -5.47%
2017 $22.46B -2.33% $4.32B 4.65% $18.15B -3.86%
2016 $23.00B -6.90% $4.13B -11.19% $18.88B -5.91%
2015 $24.71B -5.32% $4.65B -20.47% $20.06B -0.94%

Related Metrics

Explore detailed financial metrics and analysis for AZN.L.